E.C.M. van Gorp

662 total citations
9 papers, 511 citations indexed

About

E.C.M. van Gorp is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Virology. According to data from OpenAlex, E.C.M. van Gorp has authored 9 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Virology. Recurrent topics in E.C.M. van Gorp's work include HIV/AIDS drug development and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV Research and Treatment (2 papers). E.C.M. van Gorp is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers) and HIV Research and Treatment (2 papers). E.C.M. van Gorp collaborates with scholars based in Netherlands and Indonesia. E.C.M. van Gorp's co-authors include Jos H. Beijnen, Alwin D. R. Huitema, Hilde Rosing, Rob ter Heine, Jan W. Mulder, Dees P. M. Brandjes, W.M.V. Dolmans, J.W.M. van der Meer, Catharina Suharti and J W ten Cate and has published in prestigious journals such as The Journal of Infectious Diseases, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

E.C.M. van Gorp

9 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.C.M. van Gorp Netherlands 9 262 102 90 68 65 9 511
Eric C. M. Van Gorp Netherlands 13 388 1.5× 140 1.4× 148 1.6× 81 1.2× 45 0.7× 17 713
Emile F. Schippers Netherlands 14 149 0.6× 91 0.9× 30 0.3× 23 0.3× 40 0.6× 45 701
Pierre de Truchis France 13 259 1.0× 81 0.8× 148 1.6× 22 0.3× 98 1.5× 50 644
Natsuo Tachikawa Japan 16 533 2.0× 41 0.4× 217 2.4× 66 1.0× 48 0.7× 74 999
Tomoko Uehira Japan 12 212 0.8× 44 0.4× 103 1.1× 33 0.5× 10 0.2× 54 475
Sabina Mugusi Tanzania 13 364 1.4× 39 0.4× 174 1.9× 119 1.8× 16 0.2× 28 602
F. Borsa-Lebas France 10 136 0.5× 51 0.5× 98 1.1× 32 0.5× 119 1.8× 21 369
J.L. Pellegrin France 12 208 0.8× 46 0.5× 128 1.4× 21 0.3× 22 0.3× 27 463
Peter Langmann Germany 15 348 1.3× 23 0.2× 199 2.2× 68 1.0× 37 0.6× 37 555
George Perez United States 15 413 1.6× 59 0.6× 169 1.9× 22 0.3× 13 0.2× 36 785

Countries citing papers authored by E.C.M. van Gorp

Since Specialization
Citations

This map shows the geographic impact of E.C.M. van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.C.M. van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.C.M. van Gorp more than expected).

Fields of papers citing papers by E.C.M. van Gorp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.C.M. van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.C.M. van Gorp. The network helps show where E.C.M. van Gorp may publish in the future.

Co-authorship network of co-authors of E.C.M. van Gorp

This figure shows the co-authorship network connecting the top 25 collaborators of E.C.M. van Gorp. A scholar is included among the top collaborators of E.C.M. van Gorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.C.M. van Gorp. E.C.M. van Gorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Heine, Rob ter, M. J. X. Hillebrand, Hilde Rosing, et al.. (2009). Identification and Profiling of Circulating Metabolites of Atazanavir, a HIV Protease Inhibitor. Drug Metabolism and Disposition. 37(9). 1826–1840. 18 indexed citations
2.
3.
Brouwers, E. E. M., Maaike Söhne, Saskia Kuipers, et al.. (2008). Ciprofloxacin Strongly Inhibits Clozapine Metabolism. Clinical Drug Investigation. 29(1). 59–63. 32 indexed citations
4.
Heine, Rob ter, Hilde Rosing, E.C.M. van Gorp, et al.. (2008). Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 49(2). 393–400. 30 indexed citations
6.
Heine, Rob ter, Hilde Rosing, E.C.M. van Gorp, et al.. (2008). Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry. Journal of Chromatography B. 867(2). 205–212. 100 indexed citations
7.
Wagenaar, Jiri F. P., Marga G. A. Goris, Mateus Sakundarno Adi, et al.. (2006). What role do coagulation disorders play in the pathogenesis of leptospirosis?. Tropical Medicine & International Health. 12(1). 111–122. 39 indexed citations
8.
Crommentuyn, Kristel M. L., Bregt S Kappelhoff, Jan W. Mulder, et al.. (2005). Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients. British Journal of Clinical Pharmacology. 60(4). 378–389. 57 indexed citations
9.
Gorp, E.C.M. van, Catharina Suharti, W.M.V. Dolmans, et al.. (1999). Review: Infectious Diseases and Coagulation Disorders. The Journal of Infectious Diseases. 180(1). 176–186. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026